Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Study affirms effectiveness of palliative care discussions before LVAD heart surgery

For patients with severe heart failure, an implanted mechanical pump known as a Left Ventricular Assist Device (LVAD) can be a life-sustaining treatment. Even though the technology involves risks, few patients and their families tend to talk explicitly about the "what ifs" before surgery takes place.

2 Jun 2011

Eight major health systems join HVHC to demonstrate improved care at lower costs

In December, Mayo Clinic, Denver Health, Intermountain Healthcare, Dartmouth-Hitchcock, Cleveland Clinic, and The Dartmouth Institute for Health Policy and Clinical Practice announced the formation of the High Value Healthcare Collaborative to improve health care, lower costs, and move best practices out to the national provider community. Today, they announced that eight major health systems will join the Collaborative.

2 Jun 2011

New model can help determine physical fitness and cardiac health

Imagine being able to calculate one number that would tell you just how fit you are - and what that means for your heart health. Researchers from the Norwegian University of Science and Technology (NTNU) have managed exactly that: they have developed a model that can help doctors - and individuals - determine just how fit an individual is, and what that means for overall health.

2 Jun 2011

Cardiac resynchronization therapy improves sexual health in men with chronic heart failure

A new study published in the journal Clinical Cardiology reveals that in men with chronic heart failure, cardiac resynchronization therapy improves patients' libido, erectile dysfunction, and sexual performance.

2 Jun 2011

Cancer drug helps prevent hypertensive heart disease

A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.

31 May 2011

NovaShunt launches new corporate identity and product branding

NovaShunt AG has launched a new corporate identity and product branding to support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG it prepares for the upcoming launch of the ALFApump System in Europe.

30 May 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

UCB today announced data which showed that the addition of Cimzia to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.

30 May 2011

ARCA plans to expand development program for Gencaro in atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial fibrillation, a disease that affects more than 2.4 million patients in the United States.

27 May 2011

Long-term exposure to estrogen increases high blood pressure in women

For many years doctors believed the estrogen women consumed in the form of oral contraceptives and hormone replacement therapy pills was good for their patients' hearts. Recent studies however have shown that long-term exposure to estrogen can be a danger to women as it has been associated with high blood pressure, a key link to heart- and brain-attacks.

27 May 2011

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.

26 May 2011

NIH-funded analysis finds 19% of young adults with high blood pressure

Roughly 19 percent of young adults may have high blood pressure, according to an analysis of the National Longitudinal Study of Adolescent Health, which is supported by the National Institutes of Health.

26 May 2011

Baked, broiled fish consumption linked to reduced heart failure risk in postmenopausal women

The risk of developing heart failure was lower for postmenopausal women who frequently ate baked or broiled fish, but higher for those who ate more fried fish, in a study reported in Circulation: Heart Failure, an American Heart Association journal.

25 May 2011

HDL to acquire Harris Scientific

Health Diagnostic Laboratory Inc., a CAP accredited leader in health management, announced today that it will expand its comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases through the acquisition of Harris Scientific, Inc., a company providing omega-3 fatty acid testing based on the research of Dr. William Harris.

25 May 2011

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

In a new important research study out of the UK, scientists found that the specific form of Modified Citrus Pectin developed by Isaac Eliaz, M.D. interrupts deadly kidney fibrosis by binding to galectin-3 molecules, decreasing the effects of inflammation and fibrosis in acute kidney injury.

24 May 2011

Researchers discover protein switch that can trigger heart failure

Researchers at the Peter Munk Cardiac Centre discovered a protein switch which can trigger a cascade of events leading to heart failure, pointing to a new direction for drug development.

24 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Patients with chronic heart failure can benefit from telemonitoring

Two trials presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology, will help to define the precise populations of patients with chronic heart failure in whom telemedical management delivers benefits.

23 May 2011

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

23 May 2011

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

The aldosterone antagonist eplerenone significantly reduced the development of new onset atrial fibrillation and flutter in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology.

23 May 2011

Technology to determine most effective chemotherapy treatment wins first prize in UC Davis Big Bang! competition

A technology that could allow cancer specialists to better determine the most effective chemotherapy treatment for a given patient won the $10,000 in first prize money in the 11th annual Big Bang! Business Plan Competition at the University of California, Davis. The contest is run by MBA students in the Graduate School of Management.

20 May 2011

Heart Failure News and Research

Further Reading

Study affirms effectiveness of palliative care discussions before LVAD heart surgery

Eight major health systems join HVHC to demonstrate improved care at lower costs

New model can help determine physical fitness and cardiac health

Cardiac resynchronization therapy improves sexual health in men with chronic heart failure

Cancer drug helps prevent hypertensive heart disease

NovaShunt launches new corporate identity and product branding

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

ARCA plans to expand development program for Gencaro in atrial fibrillation

Long-term exposure to estrogen increases high blood pressure in women

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

NIH-funded analysis finds 19% of young adults with high blood pressure

Baked, broiled fish consumption linked to reduced heart failure risk in postmenopausal women

HDL to acquire Harris Scientific

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

Researchers discover protein switch that can trigger heart failure

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Patients with chronic heart failure can benefit from telemonitoring

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

Technology to determine most effective chemotherapy treatment wins first prize in UC Davis Big Bang! competition

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News